Form PRES14A - Preliminary proxy statements, special meeting:
SEC Accession No. 0000950123-01-502423
Filing Date
2001-05-14
Accepted
2001-05-14 00:00:00
Documents
1
Period of Report
2001-06-20

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS INC y49193ppres14a.txt PRES14A 25741
  Complete submission text file 0000950123-01-502423.txt   27316
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: PRES14A | Act: 34 | File No.: 000-15190 | Film No.: 1634186
SIC: 2835 In Vitro & In Vivo Diagnostic Substances